CMS Open Payments · Program Year 2024
Noctrix Health, Inc.
Noctrix Health, Inc. reported $118,582.49 across General Payments, Research, and Ownership to 124 physicians and teaching hospitals across 142 transactions.
- $118.6K
- All-tracks total
- 142
- Transactions
- 124
- Recipients
- #1141
- of 1,925 companies
Noctrix Health, Inc. reported $118,582.49 across all CMS Open Payments tracks (General + Research + Ownership) to 124 physicians and teaching hospitals in Program Year 2024 - ranking #1141 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $30,660.99, averaging $956.31 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer noctrix-health-inc Noctrix Health, Inc.
$118.6K · #1141/1,925 · 0.0% industry · PY2024
- TOT $118.6K
- RANK #1141
- SHARE 0.0%
- TXN 142
- RCP 124
- CAT 2
- GEN $30.7K
- TOP1 66.5%
- PY 2024
Volume peers
Nearest volume peer: Human Regenerative Technologies ($118.8K)
Noctrix Health, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Noctrix Health, Inc.
In Program Year 2024, Noctrix Health, Inc. reported $118,582.49 in payments to 124 physicians and teaching hospitals across 142 individual transactions, an average of $835.09 per transaction and $956.31 per recipient. That total places Noctrix Health, Inc. at rank #1141 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $21.0K across 9 transactions, 68.5% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Noctrix Health, Inc.'s 2-category general-payment breakdown at $21.0K, 68.5% of the reported total.
How Noctrix Health, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $21.0K | 9 | 68.5% |
| Food and Beverage | $9.7K | 115 | 31.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $22,123.63 (72.2%) of $30,660.99 in this company's General Payments records across 107 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Noctrix Health, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Haramandeep Singh
$20,400.00 across 7 reported transactions
- 2
Brenda Latowsky
$595.50 across 2 reported transactions
- 3
Margaret Heidenreich
$420.27 across 3 reported transactions
- 4
Christen Cheuvront
$420.27 across 3 reported transactions
- 5
Maureen Lally
$287.59 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Noctrix Health, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Noctrix Health, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Noctrix Health, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Forte Bio-Pharma LLC
Brainlab, Inc.
Neptune Medical Inc.
Brixton Biosciences, Inc.
Jan Medical Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.